Brief: Biomed Lublin Business Partner 4.6 Mln Zloty Offer Chosen As Most Favourable In Tender On Delivery Of Anti-Tuberculosis Vaccine

Synthaverse SA

01/02/2022 07:49

Feb 1 (Reuters) - Biomed Lublin Wytwornia Surowic i
Szczepionek SA  BML.WA :
    * COMPANY'S TRADING PARTNER OFFER WAS CHOSEN AS MOST
FAVOURABLE IN
TENDER ON DELIVERY OF ANTI-TUBERCULOSIS BCG 10 VACCINE PRODUCED
BY COMPANY
    * OFFER AT TOTAL VALUE OF 4.6 MILLION ZLOTYS
    * DELIVERY TO BE REALISED BY COMPANY IN 3 PARTS FROM FEB 28
TO OCT
28

Source text for Eikon:  ID:nEM5tR1QPa 
Further company coverage:  BML.WA 

 (Reporting by Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com;))